NRAS and melanoma: In this regards, single-site biopsy of PLA1A could be considered as a diagnostic marker of BRAF-mutant metastasis in melanoma cancer, since it is sufficiently sensitive and precise in distinguishing melanoma patients with BRAF-mutated and NRAS-mutated advanced melanoma.